» Articles » PMID: 6156979

Mode of Regulation of Natural Killer Cell Activity by Interferon

Overview
Journal J Exp Med
Date 1980 Jul 1
PMID 6156979
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Whereas xenogeneic tumors such as baby hamster kidney or HeLa cells grow in nude mice, the same cells persistently infected with a variety of viruses are rejected. Spleen cells from normal nude mice were found to be induced to produce interferon and to exert natural killer (NK) activity on virus persistently infected (PI) tumor cells, and not on uninfected parental cells in vitro. The phenotype of the interferon-producing cells and the NK effector cells was found to be the same namely, Qa 5(+), Ly 5(+), ganglio-N- tetraosylceramide, with 35 percent of the NK cells also expressing Thy 1.2. NK activity against virus PI tumor cell lines could be nonspecifically augmented both in vivo and in vitro by prior contact with virus PI tumor cells. It was unambiguously demonstrated with chemically homogeneous mouse interferon that interferon, and not a contaminant, was responsible for the augmentation of NK activity in vitro. Studies on the mode of interferon action in augmenting NK activity revealed that the target cell for interferon action was serologically distinct from the NK effector cell. Anti-Ly 5 + complement (C)-treated spleen cells were depleted of NK activity and the ability to produce interferon, but, upon incubation with interferon for 1-3 h, regained both NK activity and susceptibility to anti-Ly 5 + C. Treatment with anti-Qa 5 + C eliminated NK activity, which could not be restored by the addition of interferon. We conclude that interferon produced by Ly 5(+) cells in response to virus PI tumor cells acts on Ly 5(-) precursor cells and induces their differentiation into functional Ly 5(+) NK effector cells.

Citing Articles

Natural killer activity: early days, advances, and seminal observations.

Ortaldo J, Wiltrout R, Reynolds C Crit Rev Oncog. 2014; 19(1-2):1-13.

PMID: 24941370 PMC: 4272325. DOI: 10.1615/critrevoncog.2014011125.


Development of Sjögren's syndrome during treatment with recombinant human interferon-alpha-2b for chronic hepatitis C.

Unoki H, Moriyama A, Tabaru A, Masumoto A, Otsuki M J Gastroenterol. 1996; 31(5):723-7.

PMID: 8887042 DOI: 10.1007/BF02347624.


Predictors of survival in human immunodeficiency virus type 1-seropositive intravenous drug users.

Page J, Lai S, Fletcher M, Patarca R, Smith P, Lai H Clin Diagn Lab Immunol. 1996; 3(1):51-60.

PMID: 8770504 PMC: 170247. DOI: 10.1128/cdli.3.1.51-60.1996.


Direct and indirect effects of human interferon alpha on renal cell carcinoma: a new in vitro assay system for evaluating cytokine-mediated antitumor effects.

Matsuyama H, Yoshihiro S, Ohmoto Y, Yamamoto N, Naito K Cancer Immunol Immunother. 1993; 37(2):84-8.

PMID: 8319245 PMC: 11038512. DOI: 10.1007/BF01517039.


Role of natural killer cells in control of cancer metastasis.

Hanna N Cancer Metastasis Rev. 1982; 1(1):45-64.

PMID: 7185419 DOI: 10.1007/BF00049480.


References
1.
Kiessling R, Klein E, Wigzell H . "Natural" killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur J Immunol. 1975; 5(2):112-7. DOI: 10.1002/eji.1830050208. View

2.
Haller O, Hansson M, Kiessling R, Wigzell H . Role of non-conventional natural killer cells in resistance against syngeneic tumour cells in vivo. Nature. 1977; 270(5638):609-11. DOI: 10.1038/270609a0. View

3.
Trinchieri G, Santoli D . Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis. J Exp Med. 1978; 147(5):1314-33. PMC: 2184280. DOI: 10.1084/jem.147.5.1314. View

4.
Gidlund M, Orn A, Wigzell H, Senik A, GRESSER I . Enhanced NK cell activity in mice injected with interferon and interferon inducers. Nature. 1978; 273(5665):759-61. DOI: 10.1038/273759a0. View

5.
Herberman R, Nunn M, HOLDEN H . Low density of Thy 1 antigen on mouse effector cells mediating natural cytotoxicity against tumor cells. J Immunol. 1978; 121(1):304-9. View